Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03473560

Ligand	Ligand name	Chain	PDB	Tanimoto
9OH	(TRANS-12,13-EPOXY)-9-HYDROXY-10(E)-OCTADECENOIC ACID	A	1IK3	0.75
MRC	MUPIROCIN	A	1JZS	0.71
MRC	MUPIROCIN	A,T	1FFY	0.71
MRC	MUPIROCIN	A	1QU3	0.71
MRC	MUPIROCIN	A,T	1QU2	0.71
OLC	(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate	A	3D4S	0.72
164	2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID	A	1R6W	0.78
OPD	9R,13R-12-OXOPHYTODIENOIC ACID	A,B	1ICQ	0.88
11O	(TRANS-12,13-EPOXY)-11-HYDROXY-9(Z)-OCTADECENOIC ACID	A	1IK3	0.73
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	3DSJ	0.78
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	2RCH	0.78
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	2VST	0.78
CDZ	3,5-dihydroxy-4,6,6-tris(3-methylbut-2-en-1-yl)-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one	A	2QNV	0.7
RCL	RICINOLEIC ACID	A	2CM4	0.75
RCL	RICINOLEIC ACID	A	2CM9	0.75
RCL	RICINOLEIC ACID	A	1FK7	0.75
FUA	FUSIDIC ACID	A	1QCA	0.7
FUA	FUSIDIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1Q23	0.7
FUA	FUSIDIC ACID	A,B	2VUF	0.7
E2P	PROSTAGLANDIN B2	A	1CZ2	0.81
9HO	(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid	A,B	2VSR	0.78
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.87
ASY	(12E)-10-oxooctadec-12-enoic acid	A,B	3CEE	0.72
DL4	(14beta,17alpha,25R)-3-oxocholest-4-en-26-oic acid	A	3GYT	0.7
9OD	(2Z)-9-oxodec-2-enoic acid	A	3BFA	0.71
9OD	(2Z)-9-oxodec-2-enoic acid	A,B	3CZ0	0.71
9OD	(2Z)-9-oxodec-2-enoic acid	A,B	3CYZ	0.71
9OD	(2Z)-9-oxodec-2-enoic acid	A	3BFB	0.71
13R	13(R)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID	A	1IK3	0.76
E4H	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2HFK	0.81
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	1
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,B,E	1R8Q	0.79
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A	1RE0	0.79
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,E	1S9D	0.79
HO2	(9E,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A	3DBM	0.78
T25	(9Z)-11-[(2R,3S)-3-pentyloxiran-2-yl]undec-9-enoic acid	A,B	2RCL	0.7
T25	(9Z)-11-[(2R,3S)-3-pentyloxiran-2-yl]undec-9-enoic acid	A,B	3DSK	0.7
MEI	(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID	A,B	1UHL	0.72
1NB	2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL	P	1BRU	0.71
T24	(9Z,11E,13S,15Z)-13-hydroxyoctadeca-9,11,15-trienoic acid	A,B	3DSI	0.76
PTG	(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid	A,B	2ZK1	0.73
PTG	(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid	A	2ZK2	0.73
13S	13(S)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID	A	1IK3	0.76
6OC	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	A,B	2VV4	0.8
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.73
RGC	REIDISPONGIOLIDE C	A	2ASP	0.71
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A	2ZB4	0.84
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A,B	1V3V	0.84
6OB	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	A,B	2VV4	0.81
PGX	7-[6-(3-HYDROPEROXY-OCT-1-ENYL)-2,3-DIOXA-BICYCLO[2.2.1]HEPT-5-YL]-HEPT-5-ENOIC ACID	A,B,C,D	1DDX	0.77
1PL	(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid	A	2RDS	0.74
1PL	(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid	A	2RDN	0.74